SFG
NVS icon

Sather Financial Group’s Novartis NVS Stock Holding History

Sather Financial Group’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-4,464
Closed -$302K – 66
2018
Q2 		$302K Sell
4,464
-143
-3% -$9.87K 0.07% 64
2018
Q1 		$334K Buy
4,607
+143
+3% +$10.9K 0.08% 62
2017
Q4 		$336K Hold
4,464
– – 0.08% 57
2017
Q3 		$343K Hold
4,464
– – 0.09% 57
2017
Q2 		$334K Buy
+4,464
New +$316K 0.1% 59

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Sather Financial Group's NVS Position: Q3 2018 in Review

Sather Financial Group sold out of Novartis (NVS) in Q3 2018, closing a stake of 4,464 shares — an estimated $302K sold.

Sather Financial Group first reported a position in NVS in Q2 2017 and held it in 5 quarters. The position peaked at $343K in Q3 2017. 1,028 funds tracked by Wall St. Rank hold NVS as of Q3 2018.

  • Sather Financial Group reported no remaining Novartis position as of Q3 2018 after selling out during the quarter.
  • Sather Financial Group sold 4,464 Novartis shares in Q3 2018, an estimated $302K.
  • Sather Financial Group first reported a position in Novartis in Q2 2017 and held it in 5 quarters.
  • Sather Financial Group's Novartis position peaked at $343K in Q3 2017.
  • 1,028 funds tracked by Wall St. Rank held Novartis as of Q3 2018.

Based on Sather Financial Group's 13F filing for Q3 2018, filed 7 Nov 2018.